A new animal model for schizophrenia: cholinergic and serotonergic modulation.
D006916:5-Hydroxytryptophan / Q000494:pharmacology; D000818:Animals; D001522:Behavior, Animal / Q000187:drug effects; D003913:Dextroamphetamine; D004195:Disease Models, Animal; D004305:Dose-Response Relationship, Drug; D006801:Humans; D008297:Male; D008784:Methysergide / Q000494:pharmacology; D010627:Phenethylamines / Q000037:antagonists & inhibitors / Q000494:pharmacology; D011292:Premedication; D051381:Rats; D011950:Receptors, Cholinergic / Q000187:drug effects*; D011985:Receptors, Serotonin / Q000187:drug effects*; D012559:Schizophrenia / Q000139:chemically induced*; D013239:Stereotyped Behavior / Q000187:drug effects; D014282:Trihexyphenidyl / Q000494:pharmacology
D010627:Phenethylamines; D011950:Receptors, Cholinergic; D011985:Receptors, Serotonin; D014282:Trihexyphenidyl; D006916:5-Hydroxytryptophan; D003913:Dextroamphetamine; D008784:Methysergide